RxSight, Inc. Common Stock (RXST) is a publicly traded Healthcare sector company. As of October 20, 2026, RXST trades at $4.88 with a market cap of $195.07M and a P/E ratio of -4.13. RXST moved +3.94% today. Year to date, RXST is -52.99%; over the trailing twelve months it is -42.79%. Its 52-week range spans $4.40 to $29.69. Analyst consensus is neutral with an average price target of $7.57. Rallies surfaces RXST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for RXST, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $4.88 |
| Market Cap | $195.07M |
| P/E Ratio | -4.13 |
| EPS | $-1.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.69 |
| 52-Week Low | $4.40 |
| Volume | 396.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $127.58M |
| Net Income | $-46.95M |
| Gross Margin | 77.50% |
10 analysts cover RXST: 0 strong buy, 1 buy, 7 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $7.57.